FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4564511000001105: Sirolimus 2mg tablets 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21314901000001114 Sirolimus 2mg tablets 30 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21315001000001114 Sirolimus 2mg tablets 30 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sirolimus 2mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sirolimus 2mg tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Sirolimus 2mg tablets 30 tablet Is pack of Product containing precisely sirolimus 2 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Sirolimus 2mg tablets 30 tablet Has active ingredient Sirolimus false Inferred relationship Existential restriction modifier
Sirolimus 2mg tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sirolimus 2mg tablets 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sirolimus 2mg tablets 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Sirolimus 2mg tablets 30 tablet Has VMP Product containing precisely sirolimus 2 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Sirolimus 2mg tablets 30 tablet Has specific active ingredient Sirolimus true Inferred relationship Existential restriction modifier
Sirolimus 2mg tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Is a True Sirolimus 2mg tablets 30 tablet Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Waymade Ltd) 30 tablet Is a True Sirolimus 2mg tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start